Erlinda M. Gordon, Frederick Hall

Our Journey Beyond Sunset Boulevard

Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on ¿True¿ Long-Term Cancer-Free Survival

• Gebundenes Buch

Produktbeschreibung

The revival of DeltaRex-G (formerly Rexin-G)¿the first proactive tumor-hunting/tumor-killing biomedicine of this kind in history¿returned active tumor surveillance and a precision-guided ¿silver bullet¿ (dnG1 killer gene) to the cancer clinic with ¿Expanded Access¿ in 2019. Empowered by US Right-to-Try legislation, while honoring ethical principles of ¿informed consent,¿ this unique graphic/picturesque presentation of clinical and translational medicine is intended for postmodern (post-Enlightenment) layman readers, including cancer patients, students, researchers, and future practitioners in the field of precision gene-based medicine. Confronting logical fallacies in popular opinion, the authors present newsworthy, up-to-date clinical research documenting the successful management of refractory metastatic cancers with tumor-targeted gene therapy vectors¿validating ¿pathotropic¿ (disease-seeking) tumor targeting avant la lettre.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: IntechOpen
• Seitenzahl: 56
• Erscheinungstermin: 5. Mai 2021
• Englisch
• Abmessung: 266mm x 185mm x 9mm
• Gewicht: 346g
• ISBN-13: 9781839694158
• ISBN-10: 1839694157
• Artikelnr.: 62104580